(Q43698528)

English

Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36.

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

0 references

Leishmania infantum

1 reference

based on heuristic

inferred from title

cutaneous leishmaniasis

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

Mariano Esteban

6

object named as

M Esteban

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

R M Gonzalo

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

J R Rodríguez

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

D Rodríguez

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

G González-Aseguinolaza

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

V Larraga

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Microbes and Infection

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

701-711

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Immunology of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-12 is required to maintain a Th1 response during Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression cloning of a protective Leishmania antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective down-regulation of Th2 immune responses following treatment with antigen-coupled splenocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to Leishmania major induced by tolerance to a single antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Applications of pox virus vectors to vaccination: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36/LACK protective antigen from Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning, molecular analysis and differential cell localisation of the p36 RACK analogue antigen from the parasite protozoon Crithidia fasciculata

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Early parasite containment is decisive for resistance to Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and characterization of attenuated mutants of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility to Leishmania major infection in interleukin-4-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigens targeted to the Leishmania phagolysosome are processed for CD4+ T cell recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Designer vaccines for parasitic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1286-4579(01)01426-5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43698528&oldid=2102661349"